FDA
approval
· 2012-12-31
FDA Approved: RIZATRIPTAN BENZOATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved Glenmark's rizatriptan benzoate as an original generic application for the acute treatment of migraine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)